Clinical Trial for Evaluating the Effectiveness and Safety of the Pulse Wave-based Atrial Fibrillation and Premature Beat Alert Software

NACompletedINTERVENTIONAL
Enrollment

199

Participants

Timeline

Start Date

October 18, 2022

Primary Completion Date

March 1, 2023

Study Completion Date

March 1, 2023

Conditions
Arrhythmia, Heart
Interventions
DEVICE

ECG

Each participant undergoes testing with both the investigation device and the control device simultaneously. The results of the investigation device, which are obtained through pulse wave data analysis at the wrist, are compared to the investigator's interpretation of the ECG.

Trial Locations (1)

Unknown

Zhujiang Hospital of Southern Medical University, Guangzhou

All Listed Sponsors
lead

Huawei Device Co., Ltd

INDUSTRY